NeoGenomics

NeoGenomics provides oncology diagnostic testing and consultative services, including technical laboratory testing and professional interpretation of results by licensed physicians and molecular pathologists. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company generates revenue from clinical cancer testing, interpretation and consultative services, molecular and next-generation sequencing testing, technical and professional services, clinical trials and research, and validation laboratory services.